Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07203547) titled 'Phase 4 Study of Laybon Tab. in Knee Osteoarthritis' on Sept. 24.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).
Primary Sponsor: Mather's Pharm. Co., Ltd.
Condition:
Osteoarthritis, Knee
Osteoarthritis
Intervention:
Drug: Layla Tab.
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: December 2025
Target Sample Size: 172
To know more, visit https://clinicaltrials.gov/study/NCT07203547
Published by HT Digital Content Services with permission from H...